Skip to main content
. 2020 Dec 5;52(5):414–421. doi: 10.4103/ijp.ijp_998_20

Figure 10.

Figure 10

Forest plot showing the pooled prevalence of rash among COVID-19 patients after favipiravir treatment (Suppl. Figure: 7 (197.9KB, tif) - Funnel plot showing publication bias among studies evaluating rash among COVID-19 patients after favipiravir treatment.)